New Clinical Guidelines and Practice Updates
Be Part of the Meeting to
If you treat patients with inflammatory bowel disease, conduct
IBD research, or plan to pursue a career in IBD, join us for the
inaugural Crohn’s & Colitis Congress™, taking place Jan. 18-20,
2018, in Las Vegas, NV. The Crohn’s & Colitis Foundation (
formerly CCFA) and AGA have joined together to develop a must-attend
program for the entire IBD care team. Expand your knowledge,
network with your peers as well as IBD leaders across multiple
disciplines, and get inspired to improve care for patients with
Crohn’s disease and ulcerative colitis.
You may also be interested in the free precongress workshop
– The Lloyd Mayer, MD, Young IBD Investigators Clinical, Basic, and
Translational Research Workshop. This half-day precongress workshop
is targeted to early-career clinical, basic, and translational researchers as well
as senior researchers and will feature a mix of research presentations by young
investigator colleagues, keynote presentations, and panel discussion, featuring established IBD researchers. The theme this year is focused around grant proposals and will include two mock grant review sessions.
Learn more about the Crohn’s & Colitis Congress and register: http://crohnscolitiscongress.org. n
The latest AGA Clinical Practice Guideline, published in
Gastroenterology, is on the role of therapeutic drug monitoring (TDM) in the management of IBD. It focuses on
the application of TDM for biologic therapy, specifically
anti-tumor necrosis factor-α (TNF) agents, and for thio-purines, and addresses questions on the risks and benefits of reactive TDM, routine proactive TDM, or no TDM in
guiding treatment changes.
View the full guideline, technical review, and patient guide
In addition to guidelines, please check out the most recent Clinical Practice Updates (CPU) in Gastroenterology
and Clinical Gastroenterology and Hepatology (CGH), which
are often accompanied by a practice quiz from one of the
authors, via the AGA Community. Visit http://community.
gastro.org/guidelinecpu to test your knowledge. The most
recent CPU, published in the September issue of CGH, focuses on GI side effects related to opioid medications. n